Literature DB >> 3299872

Test of prolongation of skin graft survival by blood injections provides evidence for presence of a new histocompatibility locus in the B-G region of chicken MHC.

M Vilhelmová.   

Abstract

When used for pretransplantation treatment, blood of congenic chicken lines CB and CB.R1, incompatible only in the B-G region of the major histocompatibility complex (MHC), differed in their ability to induce prolonged survival of skin grafts transferred from either of these lines onto recipients of a third congenic line, CC. Moreover, skin grafts from CB and CB.R1 donors displayed a difference in survival time, irrespective of blood pretreatment. Graft survival time after pretreatment of recipients with CB blood could be prolonged by prior induction of neonatal tolerance to the B-G product; this could be done with injections of whole blood or of separated erythrocytes or leucocytes of line CC.R1 chickens (incompatible with CC recipients in the B-G region). The results indicate that a new histocompatibility locus is present in the B-G region of the chicken MHC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299872     DOI: 10.1111/j.1399-0039.1987.tb01556.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  Molecular genotyping of recombinant congenic lines provides evidence for crossing-over within the B-G region of the major histocompatibility complex of the chicken.

Authors:  J Plachý; A M Chaussé; P Thoraval; F Coudert
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Tumor induction by the LTR, v-src, LTR DNA in four B (MHC) congenic lines of chickens.

Authors:  J Svoboda; J Plachý; J Hejnar; I Karakoz; R V Guntaka; J Geryk
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  B-G cDNA clones have multiple small repeats and hybridize to both chicken MHC regions.

Authors:  J Kaufman; J Salomonsen; K Skjødt
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.